Chemours stock sits 17.77 percent below Mizuho's USD 15.00 target

Published on 10/17/2026 at 19:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chemours reports on November 5, 2026. Chemours stock closed at USD 12.74 on October 16, 2026, down 1.32 percent versus the NYSE close at USD 12.91.

Analyst view and report date

On October 14, 2026, Mizuho lowered its Chemours target from USD 18.00 to USD 15.00.
Second-quarter 2026 revenue reached USD 1.59 billion, down 1.50 percent year over year.
Chemours stock closed at USD 12.74 on October 16, 2026 at 4:00 p.m. ET, down 1.32 percent versus the NYSE prior close.
Chemours is scheduled to report results on November 5, 2026.

CC, US1638511089, Illustration mit AI erstellt.

Chemours (ISIN US1638511089) sits 17.77 percent below Mizuho's USD 15.00 target after the firm reiterated its Neutral rating and cut the target from USD 18.00 on October 14, 2026, according to MarketBeat. The NYSE price closed at USD 12.74 at 4:00 p.m. ET on October 16, 2026, minus 1.32 percent versus the prior close of USD 12.91.

Revenue reached USD 1.59 billion

Chemours reported revenue of USD 1.59 billion for the second quarter of 2026, down 1.50 percent from the year-earlier period. MarketBeat said the result was below a USD 1.65 billion consensus estimate. The comparison puts demand and pricing at the center of the next earnings discussion.

Stock stays near its yearly low

At USD 12.74 on October 16, 2026, Chemours stood 55.56 percent below its 52-week high of USD 28.67 and 22.03 percent above its 52-week low of USD 10.44. The stock was up 8.10 percent year to date. Trading volume reached 2,198,770 shares against an average of 2,260,382 shares.

Valuation and November date

Chemours had a market capitalization of USD 1.9 billion and a P/E ratio of -6.40 as of October 16, 2026. MetaCap lists an annual dividend yield of 2.75 percent. The company is scheduled to report results on November 5, 2026, according to MetaCap.

Comparison with peers

CC (NYSE, USD): minus 1.32 percent, P/E -6.40, market capitalization USD 1.9 billion
DuPont de Nemours (NYSE, USD): minus 0.87 percent, P/E 289.89, market capitalization USD 17.6 billion
Dow (NYSE, USD): plus 0.91 percent, P/E -16.48, market capitalization USD 21.6 billion

What the next report must clarify

The target reduction and the November 5 reporting date create two measurable checkpoints. Revenue of USD 1.59 billion, the 55.56 percent gap to the yearly high and the negative P/E ratio leave operating performance as the central market question. The further course of trading now depends on the next dated earnings update.